PJ, G., DJ, F., CA, B., S, M., & CL, V. (2026). Intermediate- versus prophylactic-dose heparin for hospitalised patients with COVID-19: An updated meta-analysis of randomised trials. Intensive care medicine, 52(4), 800. https://doi.org/10.1007/s00134-025-08128-0
Chicago Style (17th ed.) CitationPJ, Godolphin, Fisher DJ, Bradbury CA, Murthy S, and Vale CL. "Intermediate- Versus Prophylactic-dose Heparin for Hospitalised Patients with COVID-19: An Updated Meta-analysis of Randomised Trials." Intensive Care Medicine 52, no. 4 (2026): 800. https://doi.org/10.1007/s00134-025-08128-0.
MLA (9th ed.) CitationPJ, Godolphin, et al. "Intermediate- Versus Prophylactic-dose Heparin for Hospitalised Patients with COVID-19: An Updated Meta-analysis of Randomised Trials." Intensive Care Medicine, vol. 52, no. 4, 2026, p. 800, https://doi.org/10.1007/s00134-025-08128-0.